EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Emerging biomaterials for osteomyelitis treatment: from material design to anti-infection and tissue regeneration

Shi-Jiu Yin, Yu Chen, Jia Li, Hai Yang, Yi Ren, Biao Cao, Qi-Rui Geng, Jun-Qi Niu, Heng Gong, Hui Zhang

Frontiers in Cell and Developmental Biology · 03.08.2026 · 14

DOI: 10.3389/fcell.2026.1922621 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 03.08.2026. Verfasst von Shi-Jiu Yin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery and Orthopedic Research Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, China. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: West China Hospital, Sichuan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteomyelitis (OM) is an infectious disease caused by the invasion of bone tissue by pathogenic microorganisms. It is frequently associated with biofilm formation, residual sequestra, local ischemia and hypoxia, elevated oxidative stress, and immune dysfunction. Conventional treatments rely on systemic antibiotics, surgical debridement, antibiotic-loaded bone cement, and bone transport techniques. Although these approaches can control infection in some cases, they remain limited by insufficient drug penetration, nondegradable materials, the need for secondary surgery, difficulty in repairing bone defects, and the risk of recurrence. In recent years, emerging biomaterials have provided new therapeutic strategies for OM by enabling the local delivery of antimicrobial agents, antimicrobial peptides, metal ions, or gaseous molecules, often in combination with photothermal therapy, sonodynamic therapy, pH/enzyme-responsive systems, and immunomodulation. The aim of this mini-review is to briefly summarize the pathological features of OM, outline the major design strategies of biomaterials currently used for OM treatment, and discuss the challenges associated with their clinical translation.

Schlagwörter

Stichwörter der Autor:innen

antibacterial therapybiomaterialsbone regenerationdrug deliveryimmunomodulationosteomyelitis

Autor:innen und Institutionen

  • Department of Orthopedic Surgery and Orthopedic Research Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Department of Orthopaedic Surgery, Shangjin Nanfu Hospital, Chengdu, Sichuan, China.

Förderung

  • West China Hospital, Sichuan University

Zitieren

APA

Yin, S. J., Chen, Y., Li, J., Yang, H., Ren, Y., Cao, B., Geng, Q. R., Niu, J. Q., Gong, H., & Zhang, H. (2026). Emerging biomaterials for osteomyelitis treatment: from material design to anti-infection and tissue regeneration. Frontiers in Cell and Developmental Biology, 14. https://doi.org/10.3389/fcell.2026.1922621

Vancouver

Yin SJ, Chen Y, Li J, Yang H, Ren Y, Cao B, et al. Emerging biomaterials for osteomyelitis treatment: from material design to anti-infection and tissue regeneration. Frontiers in Cell and Developmental Biology. 2026;14. doi:10.3389/fcell.2026.1922621

BibTeX
@article{Yin2026,
  author = {Yin, Shi-Jiu and Chen, Yu and Li, Jia and Yang, Hai and Ren, Yi and Cao, Biao and Geng, Qi-Rui and Niu, Jun-Qi and Gong, Heng and Zhang, Hui},
  title = {Emerging biomaterials for osteomyelitis treatment: from material design to anti-infection and tissue regeneration},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2026},
  volume = {14},
  doi = {10.3389/fcell.2026.1922621}
}
Kostenlos starten →